 cutan hypersensit reaction due seroposit patient tuberculosi effect human immunodefici viru hiv tuberculosi manag patient regimen streptomycin isoniazid thiacetazon sth hiv-seroposit patient hiv-seroposit regimen streptomycin isoniazid rifampicin pyrazinamid shrz initi phase thiacetazon isoniazid TH continu phase cutan hypersensit reaction patient patient RR CI first week treatment reaction hiv-seroposit patient sth reaction hiv-seroposit patient initi phase shrz/th none hiv-seroposit patient cutan reaction isoniazid streptomycin thiacetazon patient hiv-posit toxic epiderm necrolysi result cutan reaction result major implic tuberculosi control africa